Stay updated on Abatacept Post-marketing Clinical Trial in Japan

Sign up to get notified when there's something new on the Abatacept Post-marketing Clinical Trial in Japan page.
Latest website image capture
Clouds background image

Latest updates to the Abatacept Post-marketing Clinical Trial in Japan page

  1. Check
    2 days ago
    Change Detected
    Summary
    The web page has been updated to version 2.16.5, and the previous version 2.16.4 has been removed. Additionally, information regarding the modernization of ClinicalTrials.gov data ingest scheduled for July 2025 has been deleted.
    Difference
    2%
    Check dated 2025-07-04T04:17:54.000Z thumbnail image
  2. Check
    9 days ago
    No Change Detected
  3. Check
    16 days ago
    Change Detected
    Summary
    The expected modernization date for the ClinicalTrials.gov data ingest has been updated from June 2025 to July 2025.
    Difference
    1%
    Check dated 2025-06-19T20:10:47.000Z thumbnail image
  4. Check
    23 days ago
    No Change Detected
  5. Check
    30 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.16.1 to version 2.16.2.
    Difference
    0.1%
    Check dated 2025-06-05T11:23:00.000Z thumbnail image
  6. Check
    38 days ago
    Change Detected
    Summary
    The web page has been updated to reflect a modernization of the ClinicalTrials.gov data ingest scheduled for June 2025, along with an invitation for API users to provide input. Additionally, the revision number has been updated from v2.15.2 to v2.16.1.
    Difference
    2%
    Check dated 2025-05-29T06:12:57.000Z thumbnail image
  7. Check
    66 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.15.0 to version 2.15.2.
    Difference
    0.1%
    Check dated 2025-04-30T18:03:15.000Z thumbnail image
  8. Check
    80 days ago
    Change Detected
    Summary
    The page has undergone significant content changes, including the removal of detailed study information regarding the efficacy and safety of Abatacept in combination therapy for rheumatoid arthritis, while adding a new version number and the name of a collaborator.
    Difference
    8%
    Check dated 2025-04-16T12:44:33.000Z thumbnail image

Stay in the know with updates to Abatacept Post-marketing Clinical Trial in Japan

Enter your email address, and we'll notify you when there's something new on the Abatacept Post-marketing Clinical Trial in Japan page.